Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Senovilla

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Urologia Internationalis|May 24, 2016
Robot Assisted Radical Prostatectomy in Kidney Transplant Recipients. Our Clinical Experience and a Systematic ReviewJesús Moreno Sierra, M Ciappara Paniagua, M I Galante Romo, et al.
Actas Urologicas Espanolas|January 2, 2001
[Fracture of the penis. Review of the literature and presentation of 2 cases]J Mariño del Real, J L Senovilla Pérez, J Mateos Blanco, et al.
Oncogene|March 26, 2008
Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell deathN Tajeddine, L Galluzzi, O Kepp, et al.
Cell Death & Disease|March 11, 2016
The oncolytic peptide LTX-315 triggers immunogenic cell deathH Zhou, S Forveille, A Sauvat, et al.
Oncogene|July 29, 2014
Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancerF Aranda, N Bloy, J Pesquet, et al.
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS|February 15, 2013
Robotic Anderson-Hynes dismembered pyeloplasty: initial experienceJesús Moreno-Sierra, Ignacio Castillon-Vela, Elena Ortiz-Oshiro, et al.
Actas Urologicas Espanolas|March 11, 2020
Oncologic outcomes in 408 consecutive patient cohort treated with da Vinci robot-assisted radical prostatectomyJ Moreno-Sierra, M I Galante-Romo, J L Senovilla-Perez, et al.
Cell Death and Differentiation|June 22, 2013
Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8A Q Sukkurwala, I Martins, Y Wang, et al.
Cell Death and Differentiation|August 13, 2013
Characterization of novel MPS1 inhibitors with preclinical anticancer activityM Jemaà, L Galluzzi, O Kepp, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Urologia Internationalis|May 24, 2016
Robot Assisted Radical Prostatectomy in Kidney Transplant Recipients. Our Clinical Experience and a Systematic ReviewJesús Moreno Sierra, M Ciappara Paniagua, M I Galante Romo, et al.
Actas Urologicas Espanolas|January 2, 2001
[Fracture of the penis. Review of the literature and presentation of 2 cases]J Mariño del Real, J L Senovilla Pérez, J Mateos Blanco, et al.
Oncogene|March 26, 2008
Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell deathN Tajeddine, L Galluzzi, O Kepp, et al.
Cell Death & Disease|March 11, 2016
The oncolytic peptide LTX-315 triggers immunogenic cell deathH Zhou, S Forveille, A Sauvat, et al.
Oncogene|July 29, 2014
Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancerF Aranda, N Bloy, J Pesquet, et al.
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS|February 15, 2013
Robotic Anderson-Hynes dismembered pyeloplasty: initial experienceJesús Moreno-Sierra, Ignacio Castillon-Vela, Elena Ortiz-Oshiro, et al.
Actas Urologicas Espanolas|March 11, 2020
Oncologic outcomes in 408 consecutive patient cohort treated with da Vinci robot-assisted radical prostatectomyJ Moreno-Sierra, M I Galante-Romo, J L Senovilla-Perez, et al.
Cell Death and Differentiation|June 22, 2013
Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8A Q Sukkurwala, I Martins, Y Wang, et al.
Cell Death and Differentiation|August 13, 2013
Characterization of novel MPS1 inhibitors with preclinical anticancer activityM Jemaà, L Galluzzi, O Kepp, et al.
Pageof 2